LINDA M MELENDEZ TORRES

Allopathic & Osteopathic Physicians|General Practice ORLANDO, FL NPI 1316933708

General Payments — all program years on this page

$1,402.79

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $791.51 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $791.5142

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $214.0910
2019 $29.942
2020 $84.071
2022 $76.044
2023 $207.1412
2024 $791.5142

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096566170 Novo Nordisk Inc $23.35 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096598849 Novo Nordisk Inc $12.57 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096620356 Novo Nordisk Inc $16.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096779464 Novo Nordisk Inc $24.82 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096899326 Novo Nordisk Inc $21.20 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097035407 Novo Nordisk Inc $20.50 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097041393 Novo Nordisk Inc $23.33 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097067667 Novo Nordisk Inc $14.82 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097067893 Novo Nordisk Inc $21.43 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104217807 AstraZeneca Pharmaceuticals LP $18.26 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104646165 AstraZeneca Pharmaceuticals LP $21.51 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104734737 AstraZeneca Pharmaceuticals LP $17.55 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019218 ABBVIE INC. $11.27 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019220 ABBVIE INC. $25.68 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019222 ABBVIE INC. $11.88 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019224 ABBVIE INC. $31.23 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019226 ABBVIE INC. $21.50 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019228 ABBVIE INC. $10.08 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019230 ABBVIE INC. $32.88 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019232 ABBVIE INC. $30.29 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019234 ABBVIE INC. $30.65 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019236 ABBVIE INC. $19.15 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019238 ABBVIE INC. $10.22 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105019240 ABBVIE INC. $11.21 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105861254 AstraZeneca Pharmaceuticals LP $17.22 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114785076 Exact Sciences Corporation $16.45 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114785082 Exact Sciences Corporation $15.46 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115944494 GlaxoSmithKline, LLC. $14.69 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116040076 GlaxoSmithKline, LLC. $14.66 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116359800 GlaxoSmithKline, LLC. $14.07 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116538082 GlaxoSmithKline, LLC. $13.20 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116541640 GlaxoSmithKline, LLC. $25.81 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116589435 GlaxoSmithKline, LLC. $13.07 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326253 Amgen Inc. $15.07 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326255 Amgen Inc. $15.47 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326257 Amgen Inc. $15.50 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326259 Amgen Inc. $15.50 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117326261 Amgen Inc. $20.30 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135154302 Lilly USA, LLC $22.87 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139276808 Astellas Pharma US Inc $18.31 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139368561 Astellas Pharma US Inc $19.61 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153586870 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.70 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.